kabutan

Otsuka Holdings falls for first time in 5 days on U.S. pharmaceutical company acquisition

Mon Mar 30, 2026 1:25 pm JST Catalyst

Otsuka Holdings Co., Ltd. <4578> fell for the first time in five days. After the close of trading on the 27th, the company announced that its subsidiary Otsuka Pharmaceutical will acquire U.S. pharmaceutical company Transcend Therapeutics. The acquisition will be executed through a merger in which Transcend Therapeutics will become the surviving company, merging with a special purpose company established by Otsuka Pharmaceutical. Cash will be paid to existing shareholders of Transcend Therapeutics as consideration for the merger. The company will pay $700 million at the time of acquisition completion, along with up to $525 million in earnout payments upon achievement of sales-based milestones. The acquisition is scheduled to be completed during the second quarter of fiscal 2026.

Source: MINKABU PRESS

Related Articles